Manufacturer to warn of fatal adverse reactions from blood-clotting drug and anaesthetic mix-ups A letter from Pfizer cautions healthcare professionals to use extreme caution when storing, handling and administrating IV formulations of tranexamic acid.…
Supporting pharmacists in improving the care delivered for people with cancer The Pharmaceutical Journal has launched a cancer ‘hub page’ and educational resources on blood cancer as part of continued partnership with BeiGene.… Promotional content
NICE recommends once-weekly injection for severe blood clotting disorder Efanesoctocog alfa, a once-weekly treatment for patients with severe haemophilia A, removes the need for frequent dosing, owing to its effective bleeding control.…
Haemophilia treatment first to be recommended by NICE as part of new drug pricing agreement Etranacogene dezaparovovec (Hemgenix; CSL Behring) is also the first medicinal product to enter the Innovative Medicines Fund.…
